The invention relates to peptidic compounds, which peptidic compounds are compounds of formula (I)', or a pharmaceutically acceptable salt, or solvate, or N-oxide, or stereoisomer thereof: (I)', wherein R1; R2; s; t; u; Aa78 and G1 are as defined herein. The peptidic compounds are useful in activating the Nrf2 pathway.